Robert A. Gabbay
Chairman of Clinical Advisory BoardDr. Robert A. Gabbay, also known as Bob, M.D., Ph.D., is Member of Health Advisory Board of Valendo Health, Inc from March 2024. He is Chief Scientific and Medical Officer of the American Diabetes Association and Associate Profess at Harvard Medical School. His research focuses on innovative models of diabetes care to improve diabetes outcomes. Throughout his vibrant career he has had many accomplishments as a basic science researcher, developer of patient communication tools, creator of the first broad scale diabetes registry, designer of care management training programs and leader of one of the largest primary care transformation efforts in the US around the Patient Centered Medical Home. Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality(AHRQ) and the Center for Medicare and Medicaid Innovation for his care transformation work.
Positions
- Company NameSernova Biotherapeutics IncStock CodeSEOVFPositionChairman of Clinical Advisory BoardColleagues
- JMJonathan M. N. RigbyPresident, CEO & Director
- JLJohn L. BrooksIndependent Chairman
- JTJames T. ParsonsChief Financial Officer
- MRMarylyn RigbyChief Communications Officer
- DBDavid BurkeVice President of Investor Relations
- PBPatricia BeastonSernova Biotherapeutics Inc.
- NCNorman C. W. WongMember of Scientific Advisory Board
- JDJannette DufourMember of Scientific Advisory Board
